Application 206448

Type
ANDA
Sponsor
CIPLA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NEVIRAPINENEVIRAPINETABLET, EXTENDED RELEASE;ORAL400MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
69097-403NEVIRAPINENEVIRAPINECipla USA Inc.ANDACurrent
69097-403NEVIRAPINENEVIRAPINECipla USA Inc.ANDACurrent
69097-403NEVIRAPINENEVIRAPINECipla USA Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
19722ORIG2015-11-25
10572ORIG2015-10-21